hotspot -WSS

hotspot

author：entertainment 2025-08-26 23:47:21 - browse：55538

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Johnson & Johnson sued for allegedly overpaying for workers' drugs

focus

WSS

eGenesis tests gene

The tragedy of Johnson & Johnson’s Covid vaccine

Francis Collins on trust in science and how Covid communications failed

Top private equity targets in 2023: cardiology, clinical trials, lasers

Biotech venture capitalists face new demands from investors

The Biogen Aduhelm mess could happen again

Wikipedia

hotspot

explore

In Memoriam: Notable people who died in 2023

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

State Dept. review finds Biden bears some blame for Afghanistan failures

https://cbu01.alicdn.com/img/ibank/2017/885/943/4032349588_537446334.220x220xz.jpg

Psychedelics group wrestles with new pharma identity

The CDC's new social media misinformation war

The high cost of giving birth even with insurance

Global cancer cases to surge 77% by 2050, WHO report says

Novavax promises a turnaround & Lilly roils the obesity market

Cano Health’s bankruptcy is a warning for Medicare Advantage

focus

Independent physicians launch a new lobbying group

Why doctors need education on FDA device approval process

Global cancer cases to surge 77% by 2050, WHO report says

340B reform proposal comes out of Senate working group

Think you might have Covid

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

focus

explore

explore

leisure time